222 related articles for article (PubMed ID: 32430478)
1. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
[TBL] [Abstract][Full Text] [Related]
2. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
3. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
[TBL] [Abstract][Full Text] [Related]
4. Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.
Wrangle J; Machida EO; Danilova L; Hulbert A; Franco N; Zhang W; Glöckner SC; Tessema M; Van Neste L; Easwaran H; Schuebel KE; Licchesi J; Hooker CM; Ahuja N; Amano J; Belinsky SA; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2014 Apr; 20(7):1856-64. PubMed ID: 24486589
[TBL] [Abstract][Full Text] [Related]
5. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsaroucha E; Kakolyris S; Georgoulias V; Lianidou E
Clin Chem Lab Med; 2016 Aug; 54(8):1385-93. PubMed ID: 26741346
[TBL] [Abstract][Full Text] [Related]
6. Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study.
Wever BMM; Bach S; Tibbesma M; Ter Braak TJ; Wajon D; Dickhoff C; Lissenberg-Witte BI; Hulbert A; Kazemier G; Bahce I; Steenbergen RDM
Lung Cancer; 2022 Aug; 170():156-164. PubMed ID: 35793574
[TBL] [Abstract][Full Text] [Related]
7. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
8. [The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer].
Wang P; Zhao H; Shi R; Liu X; Liu J; Ren F; Zhao Q; Zhang H; Li Y; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):314-320. PubMed ID: 32317090
[TBL] [Abstract][Full Text] [Related]
9. HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer.
Abou-Zeid A; Hashad D; Baess A; Mosaad M; Tayae E
BMC Cancer; 2023 Apr; 23(1):329. PubMed ID: 37038139
[TBL] [Abstract][Full Text] [Related]
10. A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non-Small Cell Lung Cancer and Serum DNA.
Ooki A; Maleki Z; Tsay JJ; Goparaju C; Brait M; Turaga N; Nam HS; Rom WN; Pass HI; Sidransky D; Guerrero-Preston R; Hoque MO
Clin Cancer Res; 2017 Nov; 23(22):7141-7152. PubMed ID: 28855354
[No Abstract] [Full Text] [Related]
11. Differential Prognostic Relevance of Promoter DNA Methylation of
Tanaka Y; Kosaka Y; Waraya M; Yokota K; Harada H; Kaida T; Kikuchi M; Minatani N; Nishimiya H; Katoh H; Sengoku N; Watanabe M; Yamashita K
Anticancer Res; 2019 May; 39(5):2289-2298. PubMed ID: 31092420
[TBL] [Abstract][Full Text] [Related]
12. Detection of methylated CDO1 in plasma of colorectal cancer; a PCR study.
Yamashita K; Waraya M; Kim MS; Sidransky D; Katada N; Sato T; Nakamura T; Watanabe M
PLoS One; 2014; 9(12):e113546. PubMed ID: 25469504
[TBL] [Abstract][Full Text] [Related]
13. Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome.
Deckers IA; Schouten LJ; Van Neste L; van Vlodrop IJ; Soetekouw PM; Baldewijns MM; Jeschke J; Ahuja N; Herman JG; van den Brandt PA; van Engeland M
Clin Cancer Res; 2015 Aug; 21(15):3492-500. PubMed ID: 25904753
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer.
Nishizawa N; Harada H; Kumamoto Y; Kaizu T; Katoh H; Tajima H; Ushiku H; Yokoi K; Igarashi K; Fujiyama Y; Okuwaki K; Iwai T; Watanabe M; Yamashita K
Cancer Sci; 2019 Sep; 110(9):2846-2855. PubMed ID: 31325200
[TBL] [Abstract][Full Text] [Related]
15. Identification of the methylation of p14ARF promoter as a novel non-invasive biomarker for early detection of lung cancer.
Li L; Shen Y; Wang M; Tang D; Luo Y; Jiao W; Wang Z; Yang R; Tian K
Clin Transl Oncol; 2014 Jun; 16(6):581-9. PubMed ID: 24154929
[TBL] [Abstract][Full Text] [Related]
16. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
Igarashi K; Yamashita K; Katoh H; Kojima K; Ooizumi Y; Nishizawa N; Nishiyama R; Kawamata H; Tajima H; Kaizu T; Kumamoto Y; Watanabe M
PLoS One; 2017; 12(11):e0188178. PubMed ID: 29161283
[TBL] [Abstract][Full Text] [Related]
18. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival.
Balgkouranidou I; Karayiannakis A; Matthaios D; Bolanaki H; Tripsianis G; Tentes AA; Lianidou E; Chatzaki E; Fiska A; Lambropoulou M; Kolios G; Kakolyris S
Clin Chem Lab Med; 2013 Jul; 51(7):1505-10. PubMed ID: 23403728
[TBL] [Abstract][Full Text] [Related]
19. CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.
Meller S; Zipfel L; Gevensleben H; Dietrich J; Ellinger J; Majores M; Stein J; Sailer V; Jung M; Kristiansen G; Dietrich D
Epigenetics; 2016 Dec; 11(12):871-880. PubMed ID: 27689475
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients.
Bach S; Wever BMM; van de Wiel MA; Veltman JD; Hashemi SMS; Kazemier G; Bahce I; Steenbergen RDM
Epigenetics; 2022 Oct; 17(10):1057-1069. PubMed ID: 34605346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]